This year’s Fund A Cure will be dedicated to the ARTIFICIAL PANCREAS PROJECT including the highly acclaimed Montreal-based research project headed by Dr. Rémi Rabasa-Lhoret at IRCM (Institut de recherches cliniques de Montréal). Blood glucose control is the key to preventing serious long-term complications related to high glucose levels (such as blindness or kidney failure) and reduces the risk of hypoglycemia. By automating detection of blood sugar levels and delivery of insulin in response to those levels, an artificial pancreas has the potential to drastically transform the lives of people with type 1 diabetes.
JDRF is the leading global organization funding T1D research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF collaborates with a wide spectrum of partners and is the only organization with the scientific resources, regulatory influence, and a working plan to better treat, prevent, and eventually cure T1D. But as we work to deliver advances, one fact is inescapable: increased funding is essential. Research, clinical trials and development are expensive. And for these possibilities to become life-changing realities, JDRF needs your help.